An Artificial-Intelligence-Enabled Portable Colposcopy Device for Cervical Cancer Screening in Human Papillomavirus Positive Women Treated in Kisumu County, Kenya
This clinical trial develops and tests whether an artificial-intelligence-enabled portable colposcopy device can be used for cervical cancer screening in human papillomavirus (HPV) positive women treated in Kisumu County, Kenya. Cervical cancer remains a global health challenge because effective prevention technologies are not accessible to most women around the world. Invasive cervical cancer is highly preventable through HPV vaccination and screening, diagnosis, and treatment of precancerous cervical lesions; however, these methods are often not available in low- and middle-income countries. It is recommended that simplified screening technologies be adopted in areas where women do not have effective access to the HPV vaccine. Colposcopy is the examination of the vagina and cervix using a lighted magnifying instrument called a colposcope. Traditional colposcopes are expensive and require a referral to a facility, a trained provider, and a pathologist. The colposcope used in this study, Pocket Colposcope, is low-cost, mobile, and powered by a cell phone or tablet which houses software through which patient information and corresponding images and videos can be captured, stored, and transferred between health facilities. The captured images and videos are then evaluated using an artificial intelligence program that organizes and interprets the information, which may help provide a diagnosis and help doctors make decisions regarding treatment immediately after imaging and video capture. This may be an effective way to screen for cervical cancer in HPV positive women treated in Kisumu County, Kenya.